Hyperfine, Inc. (HYPR)
1.21
-0.06
(-4.72%)
USD |
NASDAQ |
Mar 19, 16:00
1.21
0.00 (0.00%)
Pre-Market: 08:24
Hyperfine Total Liabilities (Quarterly) : 14.26M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | 15.46M |
| Celldex Therapeutics, Inc. | 55.82M |
| Plus Therapeutics, Inc. | 12.33M |
| Atossa Therapeutics, Inc. | 8.225M |
| Abeona Therapeutics, Inc. | 61.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 55.26M |
| Shareholders Equity (Quarterly) | 41.00M |
| Debt to Equity Ratio | 0.0077 |
| Current Ratio | 4.339 |
| Net Debt Paydown Yield | -0.04% |